Home › Chronic Myeloid Leukemia › New Jersey
Chronic Myeloid Leukemia clinical trials in New Jersey
4 studies for Chronic Myeloid Leukemia are looking for participants at sites in New Jersey.
Cities in New Jersey
Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1064, Hackensack
- Ascentage Investigative Site #1054, Morristown
- Ascentage Investigative Site #1098, New Brunswick
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06423911Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
- Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingPhase 2
Ages 1 to 18 · All sexes · Updated Sep 2, 2026 · NCT07354074Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Englewood Hospital and Medical Center, Englewood
- CentraState Medical Center, Freehold
- Hackettstown Medical Center, Hackettstown
- and 7 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Sep 2, 2026 · NCT05334069A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Hackensack University Medical Center, Hackensack
- Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.